CRISPR in Parasitology: Not Exactly Cut and Dried!

Slides:



Advertisements
Similar presentations
Lecture-7 Genome editing CRISPR
Advertisements

Molecular Therapy - Nucleic Acids
METHODS OF GENOME ENGINEERING: A NEW ERA OF MOLECULAR BIOLOGY
Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
Volume 8, Issue 5, Pages (May 2017)
Box Mutations in BRCA1/2 and Rad51 are associated with breast cancer
Expanding the Biologist’s Toolkit with CRISPR-Cas9
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Volume 140, Issue 2, Pages e2 (February 2011)
In vivo optimization of the tagging approach using the Act5C model locus and flow cytometry-based quantification of the Act5C-GFP tagging success. In vivo.
Approaching TERRA Firma: Genomic Functions of Telomeric Noncoding RNA
Figure 3 Endogenous repair of double-strand DNA breaks
Volume 74, Issue 4, Pages (August 2008)
Harnessing CRISPR–Cas systems for bacterial genome editing
Transcriptional Control
Gaelen T. Hess, Josh Tycko, David Yao, Michael C. Bassik 
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Donald B. Kohn, MD, Caroline Y. Kuo, MD 
Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology  Joan Ramon Guitart, Jodi L. Johnson,
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
HIV Receives a “One Two Knockout Punch”
Volume 7, Issue 1, Pages (April 2014)
Molecular Therapy - Nucleic Acids
Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Therapeutic editing of hepatocyte genome in vivo
CRISPR genome-editing: A medical revolution
ATM Creates a Veil of Transcriptional Silence
Molecular Therapy - Nucleic Acids
Andrew R. Bassett, Charlotte Tibbit, Chris P. Ponting, Ji-Long Liu 
Volume 154, Issue 6, Pages (September 2013)
Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts
Volume 153, Issue 4, Pages (May 2013)
Current Progress in Therapeutic Gene Editing for Monogenic Diseases
Volume 14, Issue 6, Pages (February 2016)
Barbara Jusiak, Sara Cleto, Pablo Perez-Piñera, Timothy K. Lu 
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Volume 140, Issue 2, Pages e2 (February 2011)
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Unlinking an lncRNA from Its Associated cis Element
Advances in Industrial Biotechnology Using CRISPR-Cas Systems
DNA Double-Strand Breaks Come into Focus
Volume 8, Issue 5, Pages (May 2017)
Molecular Therapy - Methods & Clinical Development
The role of microhomology in genomic structural variation
A CRISPR Approach to Gene Targeting
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Molecular Therapy - Nucleic Acids
Volume 153, Issue 4, Pages (May 2013)
DNA repair: Rad52 – the means to an end
Ignazio Maggio, Manuel A.F.V. Gonçalves  Trends in Biotechnology 
Volume 25, Issue 2, Pages (February 2017)
Volume 23, Issue 3, Pages (March 2015)
Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii. Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii.
CRISPR-Based Technologies for Metabolic Engineering in Cyanobacteria
Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence replacement. Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence.
Volume 16, Issue 2, Pages (February 2015)
Polq-Mediated End Joining Is Essential for Surviving DNA Double-Strand Breaks during Early Zebrafish Development  Summer B. Thyme, Alexander F. Schier 
CRISPR/Cas9: Transcending the Reality of Genome Editing
Molecular Therapy - Nucleic Acids
Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases  Johnny H. Hu, Kevin M. Davis, David R.
Ankita Shrestha, Ahamed Khan, Nrisingha Dey  Molecular Plant 
Molecular Therapy - Nucleic Acids
MMEJ plays a dominant role in double-strand DNA break repair in L
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off- target Effects in Genome Editing  Ciaran M Lee, Thomas J Cradick,
Thomas Gaj, Benjamin E Epstein, David V Schaffer  Molecular Therapy 
Volume 9, Issue 4, Pages (April 2016)
Transient CRISPR-Cas9 system.
CRISPR Craze to Transform Cardiac Biology
Engineering Globin Gene Expression
Presentation transcript:

CRISPR in Parasitology: Not Exactly Cut and Dried! Jessica M. Bryant, Sebastian Baumgarten, Lucy Glover, Sebastian Hutchinson, Najma Rachidi  Trends in Parasitology  Volume 35, Issue 6, Pages 409-422 (June 2019) DOI: 10.1016/j.pt.2019.03.004 Copyright © 2019 The Authors Terms and Conditions

Figure 1 Key Figure: Molecular Basis and Recent Advancements of CRISPR/Cas9 Technology in Parasites and Insect Vectors (A) The Cas9 protein is guided by a single guide RNA (sgRNA) to the target locus to induce a DNA double-strand break (DSB). The DSB is repaired by homology-directed repair (HDR), microhomology-mediated end joining (MMEJ), or nonhomologous end joining (NHEJ). (B) Transcriptional repression/activation via CRISPRi/a in Plasmodium falciparum. dCas9 (inactivating mutations shown in red) binding to gene promoters can interfere with transcriptional initiation or elongation [23,36]. Fusion of epigenetic effector domains to dCas9 can modulate histone modifications around the dCas9 binding site to activate or repress transcription via hyperacetylation by GCN5 or hypoacetylation by Sir2a, respectively [37]. (C) High-throughput gene knockout and tagging system in Leishmania spp. DNA repair template containing a drug-selectable marker flanked by minimal homology regions (HRs), and an optional barcode is transfected with an sgRNA template under a T7 promoter into parasites expressing Cas9 and a T7 RNA polymerase (T7 RNAP). Sandflies can be infected with mixed, barcoded knockout parasites [48,50]. (D) Inducible Cas9 expression in Trypanosoma brucei [53]. Transgenic T. brucei expresses a T7 RNAP, a Tet repressor (TetR), and Cas9 protein under a tetracycline (Tet)-inducible rRNA promotor (PrRNA). Without the addition of Tet, TetR binds to the Tet operator (TetO), inhibiting Cas9 expression. The addition of Tet leads to the removal of TetR from TetO and expression of Cas9 protein. (E) CRISPR/Cas9-based gene drive system in the Anopheles insect vector. Crossing a wild-type (gray) with a transgenic (blue) mosquito normally leads to a 50% Mendelian inheritance rate of the mutated locus in offspring (left). In a gene drive system (right), Cas9 is expressed by the transgene and induces a DSB in the wild-type allele, which is repaired using the transgene as a template [64,65]. This leads to super-Mendelian inheritance and spread of the transgene throughout the population. Trends in Parasitology 2019 35, 409-422DOI: (10.1016/j.pt.2019.03.004) Copyright © 2019 The Authors Terms and Conditions